NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/15/2017
Back to search
Official data from USPTO
INDAPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/15/2017
Trademark type
Word
Nice classes
42
Filing date
09/18/2007
Registration date
09/02/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2017
Last transaction
11/15/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/2007
First use in commerce
09/30/2007
Drawing code
4
Owner type
16
Owner location
CHAPEL HILL, NC
Examiner
BOULTON, KELLY F
Law office
L20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
INDAPHARMA, LLC
IntellPharma, LLC
Representatives
F. Michael Sajovec Williams Mullen, c/o IP Docketing
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Technical consultation to others in the field of the pharmaceutical and biotechnology industries; and product development consultation to others in the field of the pharmaceutical and biotechnology industries
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/15/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/15/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/14/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
10/18/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/02/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/06/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/05/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/04/2014
E815
TEAS SECTION 8 & 15 RECEIVED
07/17/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2008
PUBO
PUBLISHED FOR OPPOSITION
06/17/2008
NPUB
NOTICE OF PUBLICATION
05/28/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/15/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
05/13/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/13/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
05/13/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/13/2008
IUAA
USE AMENDMENT ACCEPTED
05/05/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2008
GNRT
NON-FINAL ACTION E-MAILED
05/05/2008
CNRT
NON-FINAL ACTION WRITTEN
05/05/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/02/2008
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/02/2008
ALIE
ASSIGNED TO LIE
04/02/2008
DOCK
ASSIGNED TO EXAMINER
04/01/2008
IUAF
USE AMENDMENT FILED
03/25/2008
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/25/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/25/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/25/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/25/2008
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/02/2008
GPRA
PRIORITY ACTION E-MAILED
01/02/2008
CPRA
PRIORITY ACTION WRITTEN
01/02/2008
DOCK
ASSIGNED TO EXAMINER
12/20/2007
NWAP
NEW APPLICATION ENTERED
09/21/2007
Continuous trademark protection
Get notified about every new filing that threatens INDAPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.